Stephan Kirchmaier, Promega, Walldorf

Bioluminescent tools are renowned for their versatility, sensitivity, and widespread application in research and development. Promega has accumulated decades of experience in developing effective bioluminescent technologies. These technologies seamlessly integrate biochemical, cell-based, and in vivo applications using a consistent reporter. Attendees will discover our latest advancements in T Cell therapy and AAV-based gene therapy.